TL1A as a therapeutic target in inflammatory bowel disease

被引:10
|
作者
Kokkotis, Georgios [1 ]
Bamias, Giorgos [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sotiria Hosp, Dept Internal Med 3, GI Unit, Athens, Greece
关键词
IBD; intervention; mucosal immunity; TL1A; TNFSF15; TNF-LIKE LIGAND; CYTOKINE; LYMPHOCYTES; EXPRESSION; CELL; 1A;
D O I
10.1080/1744666X.2022.2074401
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:551 / 555
页数:5
相关论文
共 50 条
  • [31] TL1A regulates TCRγδ+ intraepithelial lymphocytes and gut microbial composition
    Tougaard, Peter
    Skov, S.
    Pedersen, A. E.
    Krych, L.
    Nielsen, D. S.
    Bahl, M. I.
    Christensen, E. G.
    Licht, T. R.
    Poulsen, S. S.
    Metzdorff, S. B.
    Hansen, A. K.
    Hansen, C. H. F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (03) : 865 - 875
  • [32] Involvement of TL1A and DR3 in induction of ischaemia and inflammation in urinary bladder dysfunction in the elderly
    Wang, Wei
    Zhang, Ning
    Zhu, Xu-Hui
    He, Zhi-Song
    Wahafu, Wasilijiang
    Xu, Zhi-Qing
    Yang, Yong
    MOLECULAR MEDICINE REPORTS, 2012, 6 (02) : 434 - 438
  • [33] GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease
    Di Petrillo, Amalia
    Kumar, Amit
    Onali, Sara
    Favale, Agnese
    Fantini, Massimo Claudio
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (12) : 1981 - 1989
  • [34] Unfolded protein response: An essential element of intestinal homeostasis and a potential therapeutic target for inflammatory bowel disease
    Di Mattia, Miriam
    Sallese, Michele
    Lopetuso, Loris Riccardo
    ACTA PHYSIOLOGICA, 2025, 241 (02)
  • [35] Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
    Ashizuka, Shinya
    Inatsu, Haruhiko
    Inagaki-Ohara, Kyoko
    Kita, Toshihiro
    Kitamura, Kazuo
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2013, 14 (04) : 246 - 255
  • [36] TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis
    Zhou, Min
    Liu, Rui
    Su, Dinglei
    Feng, Xuebing
    Li, Xia
    CYTOKINE, 2014, 69 (01) : 125 - 130
  • [37] The Therapeutic Potential of Carbon Monoxide for Inflammatory Bowel Disease
    Takagi, Tomohisa
    Uchiyama, Kazuhiko
    Naito, Yuji
    DIGESTION, 2015, 91 (01) : 13 - 18
  • [38] Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
    Ashizuka, Shinya
    Kita, Toshihiro
    Inatsu, Haruhiko
    Kitamura, Kazuo
    BIOMEDICINES, 2021, 9 (08)
  • [39] TRPV4: New therapeutic target for inflammatory bowel diseases
    Vergnolle, Nathalie
    BIOCHEMICAL PHARMACOLOGY, 2014, 89 (02) : 157 - 161
  • [40] The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
    Salas, Azucena
    GUT, 2013, 62 (10) : 1392 - 1393